Ambev 6-K notes no January 2026 share trades

Ambev S.A. filed a foreign issuer report stating that in January 2026 it did not carry out any transactions in its own securities or derivatives under the terms of Brazilian Instruction #44/2021.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

Ambev S.A. filed a foreign issuer report stating that in January 2026 it did not carry out any transactions in its own securities or derivatives under the terms of Brazilian Instruction #44/2021. The company confirms its position in treasury shares, holding 145,113,436 common shares and no ADRs as of that reporting month.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Ambev (ABEV) report in this February 2026 Form 6-K?

Ambev reports that in January 2026 it carried out no transactions in its own securities or derivatives under Instruction #44/2021. The filing mainly confirms its treasury share position and fulfills a disclosure requirement for foreign private issuers.

Did Ambev (ABEV) trade its own shares or derivatives in January 2026?

No, Ambev states that no securities or derivatives operations took place in January 2026. This disclosure is made in accordance with Article 11 of Brazilian Instruction #44/2021, focused on transparency around issuer-related trading activity.

How many treasury shares does Ambev (ABEV) hold according to this 6-K?

Ambev reports a treasury position of 145,113,436 common shares. The balance is shown as both the initial and final quantity for January 2026, indicating there were no purchases, sales, or other movements in those shares during the month.

Does Ambev (ABEV) report any ADRs in treasury in this filing?

No, the company lists zero ADRs in its treasury position. The table distinguishes between common shares and ADRs, and the ADR line shows a quantity of 0.00, confirming there were no depositary receipts held in treasury for the period.

Who signed Ambev’s (ABEV) February 2026 Form 6-K?

The filing is signed on behalf of Ambev S.A. by Guilherme Fleury de Figueiredo Ferraz Parolari. He is identified in the document as the Chief Financial and Investor Relations Officer, acting as the authorized signatory for the company.

Which SEC annual report form does Ambev (ABEV) use as a foreign issuer?

Ambev indicates that it files annual reports on Form 20-F with the SEC. The document also confirms it is not relying on the Rule 12g3-2(b) exemption, marking "No" for that treatment in the foreign private issuer section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 02/11/2026 - 06:07 AM

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of February, 2026

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___ Form 40-F _______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes _______ No ___X____

INDIVIDUAL FORM

Article 11 - CVM Instruction # 44/2021

In January 2026:

( ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 44/2021.⁽¹⁾

(X) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 44/2021, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev S.A.							CPF/CNPJ: 07.526.557/0001-00
Qualification: Outstanding Shares in Treasury
Initial Balance
Securities / Derivatives			Securities Characteristics ⁽²⁾				Quantity
Securities / Derivatives			Securities Characteristics ⁽²⁾				Quantity
Shares			Common				145,113,436
ADR			Common				0.00
Transactions in the month
Securities / Derivatives	Securities Characteristics ⁽²⁾	Intermediary		Operation	Day	Quantity	Price	Volume (R$)⁽³⁾
















Final Balance
Securities / Derivatives			Securities Characteristics ⁽²⁾				Quantity
Securities / Derivatives			Securities Characteristics ⁽²⁾				Quantity
Shares			Common				145,113,436
ADR			Common				0

(1)

When filling in the form, delete the lines that do not have any information, If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 44/2021, send a statement with that information,

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others,

(3)

Quantity multiplied by price,

(*)

Each ADR is equivalent to 1 (one) share,

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: February 11, 2026


	AMBEV S.A.

	By:	/s/ Guilherme Fleury de Figueiredo Ferraz Parolari
		Guilherme Fleury de Figueiredo Ferraz Parolari Chief Financial and Investor Relations Officer

Source: View Original Filing on SEC EDGAR